Ulcerative colitis Trials in Mexico, United States
Conditions / Ulcerative colitis / Mexico, United States
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00385736 | Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01458951 | A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00505778 | A Comparison of Once a Day Dose Compared to 2 Doses/Day | COMPLETED | PHASE3 |
| NCT00783718 | Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00486031 | Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study | COMPLETED | PHASE3 |
| NCT00410410 | A Study of Abatacept in Patients With Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00151892 | Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01771809 | Long-Term Safety Of PF-00547659 In Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT01620255 | A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT00408174 | Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis | COMPLETED | PHASE3 |